Review
Medicine, General & Internal
Samantha Polly, Inga M. Muser, Anthony P. Fernandez
Summary: Cutaneous abnormalities were observed in patients infected with SARS-CoV-2, and they have been found to have diagnostic or prognostic value. The COVID-19 vaccines have also been associated with acute and delayed cutaneous reactions. This review provides an update on the cutaneous abnormalities associated with COVID-19 infection in pediatric and non-White populations, as well as common cutaneous reactions to COVID-19 vaccines.
CLEVELAND CLINIC JOURNAL OF MEDICINE
(2023)
Review
Virology
Nabeel Hussain, Preeti Agarwala, Kinza Iqbal, Hanaa Mohamed Sheikh Omar, Gurusha Jangid, Vraj Patel, Sawai Singh Rathore, Chandani Kumari, Felipe Velasquez-Botero, Guadalupe Abigail Benitez Lopez, Yogesh Vishwakarma, Airin Parvin Nipu, Noman Khurshid Ahmed
Summary: This systematic review focused on the clinical features, physical examination findings, outcomes, and underlying pathology of acute TE in COVID-19 recovered patients. Data from 19 studies with 465 patients showed that most patients recovered from hair loss, while a few had persistent hair fall. Identifying COVID-19 infection as a potential cause of acute TE can help clinicians counsel patients and relieve them from undue stress.
JOURNAL OF MEDICAL VIROLOGY
(2022)
Article
Dermatology
Hasan Aksoy, Umut Mert Yildirim, Pinar Ergen, Mehmet Salih Gurel
Summary: This study found that approximately one-quarter of individuals who have had COVID-19 developed TE, with CATE onset occurring around 7-8 weeks after infection. The presence of AGA is associated with a more severe form of COVID-19. During the pandemic, clinicians should consider a previous SARS-CoV-2 infection in patients presenting with hair loss.
DERMATOLOGIC THERAPY
(2021)
Article
Dermatology
Hailey Olds, Jesse Liu, Kevin Luk, Henry W. Lim, David Ozog, Pranita V. Rambhatla
Summary: This study retrospectively reviewed 10 cases of COVID-19 patients who developed Telogen Effluvium (TE) and found that COVID-19 infection may be a significant trigger of TE. The majority of the patients were older females, and most of them experienced hair shedding symptoms after infection. Further research is needed to understand the long-term prevalence and prognosis of TE associated with COVID-19 infection.
DERMATOLOGIC THERAPY
(2021)
Letter
Dermatology
Ralph M. Trueb, Hudson Dutra Rezende, Maria Fernanda Reis Gavazzoni Dias
Summary: Recent studies have found potential correlations between hair shedding during the COVID-19 pandemic and androgenetic alopecia and grey hair, with the severity of the disease affecting the onset and severity of hair loss.
EXPERIMENTAL DERMATOLOGY
(2021)
Article
Dermatology
Soha Abdalla Hawwam, Mayada Ismail, Esraa E. Elhawary
Summary: The clinical manifestation of COVID-19 can include telogen effluvium, characterized by diffuse hair loss. This study evaluates the use of autologous micrografts from scalp tissues as a therapeutic modality in treating COVID-19-induced telogen effluvium. The treatment showed significant improvement in hair thickness and density after 6 months.
DERMATOLOGIC THERAPY
(2022)
Review
Dermatology
Torrey Czech, Satoru Sugihara, Yoshito Nishimura
Summary: This review examines the association between COVID-19 and hair loss, finding uncertainty and a lack of strong evidence. Hair loss in COVID-19 mainly includes telogen effluvium and is reversible.
JOURNAL OF COSMETIC DERMATOLOGY
(2022)
Article
Dermatology
Omer Kutlu, Yuhanize Tas Demircan, Kenan Yildiz, Goknur Kalkan, Duriye Deniz Demirseren, Isa An, Muazzez Cigdem Oba, Selma Emre, Engin Senel, Serap Gunes Bilgili, Sevil Erdogan Savas, Aysun Sikar Akturk, Dursun Turkmen, Seray Kulcu Cakmak, Sevgi Kulakli, Abdullah Demirbas, Nihal Altunisik, Nur Cihan Cosansu, Gunes Gur Aksoy, Mustafa Tosun, Birgul Ozkesici Kurt, Nilgun Senturk, Serpil Sener, Hatice Kaya Ozden, Selami Aykut Temiz, Mehmet Fatih Atak, Hulya Suslu, Isil Deniz Oguz, Sevilay Kilic, Eda Ustaoglu, Ilteris Oguz Topal, Tugba Ozkok Akbulut, Ibrahim Korkmaz, Arzu Kilic, Pelin Hizli, Ozlem Su Kucuk, Ceyda Caytemel, Rabia Oztas Kara, Mahmut Can Koska, Kubra Tatar, Bahar Sevimli Dikicier, Senay Agirgol, Burak Aksan, Ayse Serap Karadag
Summary: This study examined the type and frequency of hair and nail disorders after COVID-19 infection. It found that the development of hair loss and nail disorders after COVID-19 seems to be related to a history of severe COVID-19.
INTERNATIONAL JOURNAL OF DERMATOLOGY
(2023)
Article
Pharmacology & Pharmacy
A. Aldahish, R. Vasudevan, H. Salem, A. Alqahtani, S. Alqasim, A. Alqhatani, M. Al Shahrani, L. Al Mohsen, M. Hajla, D. Calina, J. Sharifi-Rad
Summary: This study investigated the awareness level of TE among COVID-19 patients in the Asir region of Saudi Arabia. The results showed that most participants had poor awareness about TE. Increased hair loss was reported after COVID-19 infection, with a higher incidence among female patients.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
(2023)
Article
Medicine, General & Internal
Nehal El Hendawy Ali Awad, Zakaria M. Obaid, Mohamed S. Zaky, Mohamed L. Elsaie
Summary: This study aimed to determine the prevalence of hair disorders in females infected with COVID-19. The results showed that approximately 61.4% of the participants reported hair problems, with telogen effluvium being the most common.
IRISH JOURNAL OF MEDICAL SCIENCE
(2023)
Article
Medicine, General & Internal
Gabriella Guarnieri, Leonardo Bertagna De Marchi, Alessandro Marcon, Silvia Panunzi, Veronica Batani, Marco Caminati, Fabiana Furci, Gianenrico Senna, Mauro Alaibac, Andrea Vianello
Summary: This exploratory study suggests that hair shedding is more closely related to the severity of COVID-19 disease and post-recovery inflammation than patients' hormonal status.
ANNALS OF MEDICINE
(2022)
Article
Medicine, General & Internal
Amr M. Ammar, Ibrahim S. Ibrahim, Abbas N. Mohamed, Mohamed L. Elsaie
Summary: This study aimed to assess the prevalence of hair loss among an Egyptian population following COVID-19 vaccination. Among the participants, 23.9% reported hair loss after receiving the vaccine, with the majority experiencing it within the first two months post-vaccination.
IRISH JOURNAL OF MEDICAL SCIENCE
(2023)
Article
Medicine, General & Internal
Ashrafur Rahaman Mahadi, Md. Abdur Rafi, Tasnim Shahriar, Senjuti Seemanta, Md. Golam Rabbani, Munjarin Akter, Mahabubul Islam Majumder, M. Tasdik Hasan
Summary: This study found that many medical students experienced hair disorders such as hair loss during the COVID-19 pandemic. COVID-19-related stress and fear potentially have an association with these diseases.
FRONTIERS IN MEDICINE
(2022)
Review
Dermatology
Marius Nicolae Popescu, Mihai Berteanu, Cristina Beiu, Liliana Gabriela Popa, Mara Madalina Mihai, Madalina Gabriela Iliescu, Ana Maria Alexandra Stanescu, Anca Mirela Ionescu
Summary: Post-COVID-19 telogen effluvium is a sequela in the post-acute phase of COVID-19 and causes significant emotional distress among patients. Physicians should be familiar with this phenomenon and provide appropriate counseling. This article reviews evidence-based complementary strategies to enhance hair regrowth after post-COVID-19 hair loss, including psychological support, patient education, optimal nutrition, oral nutritional supplementation, and the role of topical and injectable hair growth stimulators.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY
(2022)
Article
Medicine, General & Internal
Nasrin Saki, Fatemeh Sari Aslani, Mozhdeh Sepaskhah, Mohadese Shafiei, Sara Alavizadeh, Seyed Ali Hosseini, Fatemeh Ansari Asl, Najmeh Ahramiyanpour
Summary: COVID-19 is one of the causes of telogen effluvium (TE), which can result in acute or chronic hair loss. We presented a case of a 17-year-old girl with severe and widespread hair loss following an upper respiratory infection suspected to be COVID-19, with a history of similar symptoms since childhood. Evidence from biopsy and dermoscopy confirmed the diagnosis of TE.
CLINICAL CASE REPORTS
(2022)
